1428764-99-1

Upstream product

• 1428765-44-9 tert-butyl N-(4-(3-((2-m-tolyl-6-(trifluoromethyl)pyridin-3-yl)methyl)ureido)benzyl)sulfamoylcarbamate 
• 1402586-15-5 tert-butyl N-(4-aminobenzyl)sulfamoyl-carbamate 
• 1402586-14-4 tert-butyl N-(4-nitrobenzyl)sulfamoylcarbamate 
• 100-11-8 1-bromomethyl-4-nitro-benzene 
• 99-99-0 1-methyl-4-nitrobenzene 
• 1428765-31-4 2-m-tolyl-6-(trifluoromethyl)nicotinonitrile 
• 17933-03-8 m-tolylboronic acid 
• 386704-06-9 2-chloro-6-(trifluoromethyl)nicotinonitrile 
• 7409-30-5 p-nitrobenzylamine 
• 62133-07-7 2-(4-nitrobenzyl)-1H-isoindole-1,3(2H)-dione 
• 39628-94-9 4-nitrobenzyl methanesulfonate 
• 619-73-8 4-nitrobenzyl chloride 
• 1428765-32-5 (2-m-tolyl-6-(trifluoromethyl)pyridin-3-yl)methanamine 
• 1402586-16-6 N-[4-[[(tert-butoxycarbonyl-sulfamoyl)amino]-methyl]-phenyl]-carbamic acid phenyl ester 

Relevant academic research and scientific papers

Aryl or N-heteroaryl Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands

The invention relates to aryl or N-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

ARYL OR N-HETEROARYL SUBSTITUTED METHANESULFONAMIDE DERIVATIVES AS VANILLOID RECEPTOR LIGANDS

The invention relates to aryl or N-heteroaryl substituted methanesulfonamide derivatives of Formula (I) as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.